| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 03/23/2004 | US6710035 Interstitial introduction of an isolated polynucleotide into a tissue of the vertebrate where polynucleotide is taken up by the cells of the tissue and exerts a therapeutic effect on the vertebrate to provide immune response |
| 03/23/2004 | US6709865 Isolated nucleic acid molecule comprising specified nucleotide sequence which encodes polypeptide having lipoxygenase activity; modulating development and defense response in plants |
| 03/23/2004 | US6709859 Chromosomal DNA Fragments Encoding Enzymes for Encoding B-Lactam Biosynthesis Enzymes, and Vector and Transformants for Their Expression |
| 03/23/2004 | US6709851 Stabilization of helicobacter urease |
| 03/23/2004 | US6709850 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 03/23/2004 | US6709847 Immobilized enzyme for use in the generation of preferential nitrogen compounds |
| 03/23/2004 | US6709841 Generating preferential polypeptide; obtain cell, transform with vector coding preferential polypeptide, recover polypeptide |
| 03/23/2004 | US6709834 Hybrid nucleotide sequence |
| 03/23/2004 | US6709820 Materials and methods for detection of Oxalobacter formigenes |
| 03/23/2004 | US6709653 Amino acid residues 1 to 265 of sequence 2; psychotic and depressive disorders |
| 03/19/2004 | CA2400254A1 Compositions and methods for treating heart disease |
| 03/18/2004 | WO2004023270A2 Crystal structure of angiotensin-converting enzyme-related carboxypeptidase |
| 03/18/2004 | WO2004022776A2 Gtp cyclohydrolase ii as a target for fungicides |
| 03/18/2004 | WO2004022765A2 Method for hydrolysing carotenoids esters |
| 03/18/2004 | WO2004022764A2 Use of malate dehydrogenase for nadh regeneration |
| 03/18/2004 | WO2004022756A2 Protein kinases |
| 03/18/2004 | WO2004022755A2 Polypeptides involved in the regulation of flowering in forage grasses |
| 03/18/2004 | WO2004022752A1 Smg-1-binding protein and method of screening substance controlling its activity |
| 03/18/2004 | WO2004022750A1 Novel diagnostic and therapeutic methods and reagents therefor |
| 03/18/2004 | WO2004022748A1 Methods for gene silencing in transgenic animals |
| 03/18/2004 | WO2004022735A1 Method for producing a plant with a high-growth rate |
| 03/18/2004 | WO2004022734A1 Carotene-specific lipase |
| 03/18/2004 | WO2004022733A1 Novel enzyme forming peptide, microorganism producing the same and process for producing dipeptide using them |
| 03/18/2004 | WO2004022732A1 Method of purifying protein and glucose dehydrogenase |
| 03/18/2004 | WO2004022709A2 Epitope sequences |
| 03/18/2004 | WO2004022697A2 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 03/18/2004 | WO2004022683A1 A microbial oxidoreductase |
| 03/18/2004 | WO2004022598A1 Fused protein with the function of both hemolysis and anticoagulation and the use of it |
| 03/18/2004 | WO2004022592A1 Use of human protein kinase c-eta in methods for identification of pharmaceutically useful agents |
| 03/18/2004 | WO2004022091A1 Diacylglycerol production promoter |
| 03/18/2004 | WO2004022089A1 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 03/18/2004 | WO2004021981A2 METHODS FOR THE PREPARATION OF β-AMINO ACIDS |
| 03/18/2004 | WO2004011641A3 Crystal structure of beta-site app-cleaving enzyme (bace) mutants and uses thereof |
| 03/18/2004 | WO2004011424A3 Side chain anchored thioester and selenoester generators |
| 03/18/2004 | WO2004009760A3 Cytochrome p450 genetic variations |
| 03/18/2004 | WO2004006962A3 A tissue factor binding immunoconjugate comprising factor viia |
| 03/18/2004 | WO2004003216A3 Sterilization of a fermentation medium comprising hydrolysed n-source |
| 03/18/2004 | WO2004003208A3 Stress tolerant plant |
| 03/18/2004 | WO2004003187A3 Mpg added to fermentation |
| 03/18/2004 | WO2004003186A3 Subtilases and subtilase variants having altered immunogenicity |
| 03/18/2004 | WO2003102201A3 Methods and materials for the production of d-lactic acid in yeast |
| 03/18/2004 | WO2003087149A3 Bacillus licheniformis mutant host cell |
| 03/18/2004 | WO2003087146A3 Purified polypeptides from s. aureus, h. pylori and e. coli involved in cellular transport and metabolism |
| 03/18/2004 | WO2003080825A3 Further bmp-2 inducible kinases and the uses thereof |
| 03/18/2004 | WO2003076461A3 Dimeric tf antagonist comprising two factor vii polypeptides |
| 03/18/2004 | WO2003072792A3 A method of selectively producing male or female sterile plants |
| 03/18/2004 | WO2003072751A3 Expression system for human brain-specific voltage-gated sodium channel, type 1 |
| 03/18/2004 | WO2003070965A3 The eaat2 promoter and uses thereof |
| 03/18/2004 | WO2003066668A3 Peptide deformylase |
| 03/18/2004 | WO2003048361A3 P55pik |
| 03/18/2004 | WO2003037261A3 Methods and compositions for the treatment and diagnosis of pain disorders using 9805 |
| 03/18/2004 | WO2003025195A3 Nucleic acid constructs for the delivery of polynucleotides into dna-containing organelles,and uses thereof |
| 03/18/2004 | WO2003014308A3 Cysteine mutants and methods for detecting ligand binding to biological molecules |
| 03/18/2004 | WO2003012028A3 Line retrotransposable elements with rnase h enzyme activity and use of same |
| 03/18/2004 | WO2003006641A3 Epsti1, a gene induced by epithelial-stromal interaction in human breast cancer |
| 03/18/2004 | WO2002103024A3 Stabilized proteins with engineered disulfide bonds |
| 03/18/2004 | WO2002095034A9 A retinoic acid metabolizing cytochrome p450 |
| 03/18/2004 | WO2002092020A3 Compositions and methods for modulating bone mineral deposition |
| 03/18/2004 | WO2002090578A3 Methods and means of histone methylation |
| 03/18/2004 | WO2002090570A3 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression |
| 03/18/2004 | WO2002089498A3 Selection method |
| 03/18/2004 | US20040055040 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins |
| 03/18/2004 | US20040055039 Expression vector coding regulatory sequence for transcription of heterologous nucleotide sequences in fruit of plants; tissue engineering |
| 03/18/2004 | US20040055038 Methods and compositions for regulated transcription and expression of heterologous genes |
| 03/18/2004 | US20040055032 Pyrophosphatase stress-related proteins and methods of use in plants |
| 03/18/2004 | US20040055023 Animal models which concurrently expresses insulin and glucokinase gene in muscle cells; treating pancreatic disorders |
| 03/18/2004 | US20040054157 Comprises oxygenase polypeptide for diagnosis, treatment or prevent of nervous system, cell proliferative, metabolic and smooth muscle disorders |
| 03/18/2004 | US20040054149 Modified proteolytic enzyme for treatment of osteoarthritis |
| 03/18/2004 | US20040054148 Comprises immunoglobulin which preferentially binds aspartate-specific cysteine proteases (ASCPs) for treating and preventing autoimmune, ischemic and neurodegenerative diseases |
| 03/18/2004 | US20040054138 Hydrolase for diagnosis, preventiong and treatment of eye, nervous system, cardiovascular, cell proliferative and autoimmune/inflammatory disorders |
| 03/18/2004 | US20040054135 Calcineurin polypeptide for diagnosis and treatment of cardiovascular disorders |
| 03/18/2004 | US20040054134 Hcv ns2/3 fragments and uses thereof |
| 03/18/2004 | US20040054132 Comprises fatty acid-conjugated products with disulfide linkage to proteins/peptides for delivery to cells; increases absorption and prolongs blood and tissue retention |
| 03/18/2004 | US20040053912 An enzymatic deacylation of a beta -lactam compound ( containing a beta-lactam nucleus with a side chain coupled to it via an amide bond) in presence of organic solvent, and leads to a beta-lactam nucleus and a carboxylic acid |
| 03/18/2004 | US20040053893 Comprises lysophospholipids attached to chromophore; enzyme inhibitors; drug screening; kits |
| 03/18/2004 | US20040053878 Zipper protein kindase and uses thereof |
| 03/18/2004 | US20040053872 Administering polynucletides that inhibit interactions polymerases with tRNA, to humans for prophylaxis of aquired immune deficiency syndrome |
| 03/18/2004 | US20040053845 Modified peptides as therapeutic agents |
| 03/18/2004 | US20040053840 Using reagents that regulate human cyclophilin-like protein and reagents which bind to human cyclophilin-like protein gene products in preventing, ameliorating, or correcting dysfunctions or diseases including cancer |
| 03/18/2004 | US20040053836 Method for modulating the production of a selected protein in vivo |
| 03/18/2004 | US20040053834 Relates to nucleic acid and amino acid sequences of enzymes involved in glycoprotein and glycolipid metabolism and use of these in diagnosis, treatment, and prevention of carbohydrate metabolism, cell proliferative, genetic, transport disorders |
| 03/18/2004 | US20040053412 Cells resistant to toxic genes and uses thereof |
| 03/18/2004 | US20040053408 Comprises anticoagulant/thrombolytic agent for selective dissolution of fibrin clots |
| 03/18/2004 | US20040053405 Matrix reactor and a method for producing products in said reactor |
| 03/18/2004 | US20040053394 Human kinases |
| 03/18/2004 | US20040053390 Generating mutant aminoacyl transfer RNA synthetase for de novo design of artificial proteins |
| 03/18/2004 | US20040053387 Comprises nucleotide sequences coding pholem immobilized transferase fused to insecticidal proteins for generating disease resistant plants |
| 03/18/2004 | US20040053386 Terpene synthase having a region with 20% or greater sequence identity to specific residues of perferential amino acid sequence, and such synthase containing nine alpha-carbon having interatomic distance +-2.3 Angstroms between alpha C |
| 03/18/2004 | US20040053385 Comprises crystalline three dimensional configuration of selenomethionine ketopantoate hydroxymethyltransferase (KPHMT) for use in computer modeling and rational drug design |
| 03/18/2004 | US20040053383 Crystals of cytochrome P450 2C9, structures thereof and their use |
| 03/18/2004 | US20040053379 Method of producing polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs |
| 03/18/2004 | US20040053377 Methods for producing hydroxy amino acids and derivatives thereof |
| 03/18/2004 | US20040053373 Method for glucose production with improved recovery and reuse of enzyme |
| 03/18/2004 | US20040053372 Comprises prothrombin amino acid sequences for treating thrombosis and blood disorders |
| 03/18/2004 | US20040053369 Dipeptidyl peptidases |
| 03/18/2004 | US20040053361 Nucleic acid construct useful for expressing transgenes in particular in embryonic stem cells |
| 03/18/2004 | US20040053360 Preparing proteolytic polypeptide comprising amino acid attachment at carboxy-terminal for reducing odors generated when washing textiles solied with milk fat |
| 03/18/2004 | US20040053358 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/18/2004 | US20040053323 Method of screening inducible nitric oxide synthase activation inhibitor |
| 03/18/2004 | US20040053314 ADAM20 (SVPH1-26) DNA and polypeptides |